Skip header and navigation

50 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
October 29, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 RR Table EOC
October 29, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 RR EOC
October 21, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 ESR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR Table EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
July 12, 2021 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602 RR Table Epidemiology & Modelling
July 12, 2021 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602 RR Epidemiology & Modelling
July 9, 2021 What is the incidence and duration of Long COVID cases? EPM210601 RR Epidemiology & Modelling
July 9, 2021 What is the incidence and duration of long COVID cases? EPM210601 RR Table Epidemiology & Modelling
June 25, 2021 What is the incidence and duration of long COVID cases? EPM210601 ESR Epidemiology & Modelling
June 25, 2021 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602 ESR Epidemiology & Modelling
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
April 6, 2021 How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals CC210301 RR Critical Care
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
March 31, 2021 How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals CC210301 ESR Critical Care
February 27, 2021 What is the final disposition of post-COVID patients who require chronic ventilation in the ICU? CC011101 RR Critical Care
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR Table EOC

50 records – page 1 of 3.